143 related articles for article (PubMed ID: 15379942)
41. Late recurrence in 1263 men with testicular germ cell tumors. Multivariate analysis of risk factors and implications for management.
Shahidi M; Norman AR; Dearnaley DP; Nicholls J; Horwich A; Huddart RA
Cancer; 2002 Aug; 95(3):520-30. PubMed ID: 12209744
[TBL] [Abstract][Full Text] [Related]
42. Long-term follow-up of patients with poor prognosis germ cell tumor treated with early high-dose chemotherapy with hematopoietic progenitor cell support: a single-center experience.
De Giorgi U; Rosti G; Papiani G; Marangolo M
Bone Marrow Transplant; 2004 Mar; 33(6):639-43. PubMed ID: 14730335
[TBL] [Abstract][Full Text] [Related]
43. Compliance and outcome of patients with stage 1 non-seminomatous germ cell tumors (NSGCT) managed with surveillance programs in seven Canadian centres.
Ernst DS; Brasher P; Venner PM; Czaykowski P; Moore MJ; Reyno L; Winquist E; Segal R; Hao D
Can J Urol; 2005 Apr; 12(2):2575-80. PubMed ID: 15877938
[TBL] [Abstract][Full Text] [Related]
44. Pattern of relapse after first line treatment of advanced stage germ-cell tumors.
Fléchon A; Culine S; Théodore C; Droz JP
Eur Urol; 2005 Dec; 48(6):957-63; discussion 963-4. PubMed ID: 16084010
[TBL] [Abstract][Full Text] [Related]
45. Prognostic factors for survival of patients with advanced gastric cancer treated with cisplatin-based chemotherapy.
Kim JG; Ryoo BY; Park YH; Kim BS; Kim TY; Im YH; Kang YK
Cancer Chemother Pharmacol; 2008 Feb; 61(2):301-7. PubMed ID: 17429626
[TBL] [Abstract][Full Text] [Related]
46. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
[TBL] [Abstract][Full Text] [Related]
47. Predictive factors for response and prognostic factors for long-term survival in consecutive, single institution patients with locally advanced and/or metastatic transitional cell carcinoma following cisplatin-based chemotherapy.
Jessen C; Agerbaek M; Von Der Maase H
Acta Oncol; 2009; 48(3):411-7. PubMed ID: 18798018
[TBL] [Abstract][Full Text] [Related]
48. Survival of patients with nonseminomatous germ cell cancer: a review of the IGCC classification by Cox regression and recursive partitioning.
van Dijk MR; Steyerberg EW; Stenning SP; Dusseldorp E; Habbema JD
Br J Cancer; 2004 Mar; 90(6):1176-83. PubMed ID: 15026798
[TBL] [Abstract][Full Text] [Related]
49. Testis cancer: a 20-year epidemiological review of the experience at a regional military medical facility.
Cooper DE; L'esperance JO; Christman MS; Auge BK
J Urol; 2008 Aug; 180(2):577-81; discussion 581-2. PubMed ID: 18554661
[TBL] [Abstract][Full Text] [Related]
50. Histological outcome of delayed orchidectomy after primary chemotherapy for metastatic germ cell tumour of the testis.
Ramani VA; Grey BR; Addla SK; Dunham MP; Sangar VK; Clarke NW
Clin Oncol (R Coll Radiol); 2008 Apr; 20(3):247-52. PubMed ID: 18093814
[TBL] [Abstract][Full Text] [Related]
51. Testicular function in poor-risk nonseminomatous germ cell tumors treated with methotrexate, paclitaxel, ifosfamide, and cisplatin combination chemotherapy.
Pectasides D; Pectasides E; Papaxoinis G; Skondra M; Gerostathou M; Karageorgopoulou S; Kamposioras C; Tountas N; Koumarianou A; Psyrri A; Macheras A; Economopoulos T
J Androl; 2009; 30(3):280-6. PubMed ID: 19136393
[TBL] [Abstract][Full Text] [Related]
52. Impact of the number of positive lymph nodes on disease-free survival in patients with pathological stage B1 nonseminomatous germ cell tumor.
Beck SD; Foster RS; Bihrle R; Cheng L; Ulbright TM; Donohue JP
J Urol; 2005 Jul; 174(1):143-5. PubMed ID: 15947600
[TBL] [Abstract][Full Text] [Related]
53. Failure of high-dose cyclophosphamide and etoposide combined with double-dose cisplatin and bone marrow support in patients with high-volume metastatic nonseminomatous germ-cell tumours: mature results of a randomised trial.
Droz JP; Kramar A; Biron P; Pico JL; Kerbrat P; Pény J; Curé H; Chevreau C; Théodore C; Bouzy J; Culine S;
Eur Urol; 2007 Mar; 51(3):739-46; discussion 747-8. PubMed ID: 17084512
[TBL] [Abstract][Full Text] [Related]
54. Adjuvant chemotherapy for radically resected non-small cell lung cancer: a retrospective analysis of 311 consecutively treated patients.
Dediu M; Horvat T; Tarlea A; Anghel R; Cordos I; Miron G; Iorga P; Alexandru A; Nistor C; Grozavu C; Savu C
Lung Cancer; 2005 Jan; 47(1):93-101. PubMed ID: 15603859
[TBL] [Abstract][Full Text] [Related]
55. Nondysgerminomatous ovarian tumors: clinical characteristics, treatment, and outcome. A case-controlled study.
Ghaemmaghami F; Hasanzadeh M; Karimi Zarchi M; Fallahi A
Int J Surg; 2008 Oct; 6(5):382-6. PubMed ID: 18715834
[TBL] [Abstract][Full Text] [Related]
56. Laparoscopic retroperitoneal lymphadenectomy for stage I non-seminomatous testicular tumors.
Custureri F; Urciuoli P; Iavarone C; D'Orazi V; Gabatel R; Ghinassi S; Patrizi G; Palazzini G; Di Matteo FM; Peparini N
Hepatogastroenterology; 2005; 52(66):1677-80. PubMed ID: 16334755
[TBL] [Abstract][Full Text] [Related]
57. Advances in the management of metastatic non-seminomatous germ cell tumours during the cisplatin era: a single-institution experience.
Gerl A; Clemm C; Schmeller N; Hartenstein R; Lamerz R; Wilmanns W
Br J Cancer; 1996 Oct; 74(8):1280-5. PubMed ID: 8883418
[TBL] [Abstract][Full Text] [Related]
58. [New treatments for germ cell tumors with poor prognosis].
Arance A; García del Muro X; Montes A; Germà Lluch JR
Arch Esp Urol; 2000; 53(6):517-21. PubMed ID: 11002520
[TBL] [Abstract][Full Text] [Related]
59. Histologic type, staging, and distribution of germ cell tumors in Korean adults.
Park DS; Chung MK; Chung JI; Ahn HJ; Lee ES; Choi HY; Yoon DK; Cheon J; Hong SJ; Lee YG; Yoon SM; Kim WJ; Kim HJ; Ryu SB; Ro JY
Urol Oncol; 2008; 26(6):590-4. PubMed ID: 18367106
[TBL] [Abstract][Full Text] [Related]
60. Etoposide and cisplatin chemotherapy for metastatic good-risk germ cell tumors.
Kondagunta GV; Bacik J; Bajorin D; Dobrzynski D; Sheinfeld J; Motzer RJ; Bosl GJ
J Clin Oncol; 2005 Dec; 23(36):9290-4. PubMed ID: 16361627
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
